|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
WO1990003430A1
(en)
|
1988-09-23 |
1990-04-05 |
Cetus Corporation |
Cell culture medium for enhanced cell growth, culture longevity and product expression
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
FI903489A7
(fi)
|
1988-11-11 |
1990-07-10 |
Medical Res Council |
Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
|
|
US5530101A
(en)
*
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
ES2246502T3
(es)
|
1990-08-29 |
2006-02-16 |
Genpharm International, Inc. |
Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
|
FI941572L
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
|
|
CA2372813A1
(en)
|
1992-02-06 |
1993-08-19 |
L.L. Houston |
Biosynthetic binding protein for cancer marker
|
|
DE69308573T2
(de)
|
1992-08-17 |
1997-08-07 |
Genentech Inc |
Bispezifische immunoadhesine
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP0914452A2
(en)
|
1996-06-17 |
1999-05-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel ptp20, pcp-2, bdp1, clk and sirp proteins and related products and methods
|
|
US6143559A
(en)
|
1996-11-18 |
2000-11-07 |
Arch Development Corporation |
Methods for the production of chicken monoclonal antibodies
|
|
EP1972194A1
(en)
|
1996-12-03 |
2008-09-24 |
Amgen Fremont Inc. |
Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
|
|
CA2226962A1
(en)
|
1998-02-16 |
1999-08-16 |
Marie Sarfati |
Use of binding agents to cd47 and its ligands in the treatment or the prophylaxis of various inflammatory, autoimmune and allergic diseases and in the treatment of graft rejection
|
|
EP1048299A1
(en)
|
1999-04-28 |
2000-11-02 |
Faculteit der Geneeskunde van de Vrije Universiteit |
Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
|
|
EP1244707A1
(de)
|
1999-11-30 |
2002-10-02 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Antikörper gegen signal-regulator-proteine
|
|
GB9930706D0
(en)
|
1999-12-24 |
2000-02-16 |
Medical Res Council |
Composition for inhibiting macrophage activity
|
|
EP1355919B1
(en)
*
|
2000-12-12 |
2010-11-24 |
MedImmune, LLC |
Molecules with extended half-lives, compositions and uses thereof
|
|
US7282556B2
(en)
|
2001-05-15 |
2007-10-16 |
Emory University |
Polynucleotides and polypeptides relating to the modulation of SIRPα-CD47
|
|
WO2004065417A2
(en)
|
2003-01-23 |
2004-08-05 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
|
WO2005014653A2
(en)
|
2003-02-28 |
2005-02-17 |
Protein Design Labs, Inc. |
Humanized chicken antibodies
|
|
US20040213792A1
(en)
|
2003-04-24 |
2004-10-28 |
Clemmons David R. |
Method for inhibiting cellular activation by insulin-like growth factor-1
|
|
US20100215640A1
(en)
|
2003-04-24 |
2010-08-26 |
The University Of North Carolina At Chapel Hill |
Method for inhibiting cellular activation by insulin-like growth factor-1
|
|
US8613922B2
(en)
|
2003-04-24 |
2013-12-24 |
The University Of North Carolina At Chapel Hill |
Methods for inhibiting diabetic retinopathy with an antibody against integrin associated protein (IAP)
|
|
TWI306862B
(en)
|
2005-01-03 |
2009-03-01 |
Hoffmann La Roche |
Antibodies against il-13 receptor alpha 1 and uses thereof
|
|
CN101287764B
(zh)
|
2005-10-12 |
2013-11-13 |
莫佛塞斯公司 |
特异性针对人CD38的完全人HuCAL GOLD-衍生治疗抗体的生成和鉴定
|
|
JP2011500005A
(ja)
|
2007-10-11 |
2011-01-06 |
ユニバーシティー ヘルス ネットワーク |
ヒト造血幹細胞の生着を増加させるためのＳＩＲＰα−ＣＤ４７相互作用の調節およびそのための化合物
|
|
PT3056515T
(pt)
|
2008-01-15 |
2019-07-19 |
Univ Leland Stanford Junior |
Métodos para manipulação da fagocitose mediada por cd47
|
|
CA2711370C
(en)
|
2008-01-15 |
2017-06-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Markers of acute myeloid leukemia stem cells
|
|
JP5737707B2
(ja)
|
2008-03-04 |
2015-06-17 |
クリスタル バイオサイエンス インク．Ｃｒｙｓｔａｌ Ｂｉｏｓｃｉｅｎｃｅ Ｉｎｃ． |
ゲル状マイクロドロップ組成物およびその使用方法
|
|
EP2111869A1
(en)
|
2008-04-23 |
2009-10-28 |
Stichting Sanquin Bloedvoorziening |
Compositions and methods to enhance the immune system
|
|
EP2464220A4
(en)
|
2009-08-13 |
2014-05-07 |
Crystal Bioscience Inc |
Transgenic animal for the production of antibodies with minimal complementarity-determining regions
|
|
WO2011041453A1
(en)
|
2009-09-29 |
2011-04-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Isolation and use of melanoma cancer stem cells
|
|
ES2724198T3
(es)
|
2010-08-27 |
2019-09-09 |
Univ Health Network |
Métodos para enriquecer células progenitora de cardiomiocitos derivadas de células madre pluripotentes y células cardiomiocitos basándose en la expresión de SIRPA
|
|
US9380769B2
(en)
|
2011-05-24 |
2016-07-05 |
Crystal Bioscience Inc. |
Transgenic chicken comprising an inactivated immunoglobulin gene
|
|
WO2013056352A1
(en)
*
|
2011-10-19 |
2013-04-25 |
University Health Network |
Antibodies and antibody fragments targeting sirp-alpha and their use in treating hematologic cancers
|
|
US9394372B2
(en)
|
2011-10-21 |
2016-07-19 |
Crystal Bioscience Inc. |
In vivo method for generating diversity in a protein scaffold
|
|
DK3421601T3
(da)
|
2011-12-30 |
2020-02-24 |
Cellscript Llc |
Fremstilling og anvendelse af in-vitro-syntetiseret ssRNA til indføring i pattedyrceller med henblik på at inducere en biologisk eller biokemisk effekt
|
|
DK4389764T3
(da)
|
2012-11-05 |
2026-04-13 |
Regeneron Pharma |
Genetisk modificerede gnavere og fremgangsmåder til anvendelse heraf
|
|
ME03550B
(me)
|
2012-12-17 |
2020-07-20 |
Trillium Therapeutics Inc |
Lečenje cd47+ obolelih ćelija sa sirp alfa-fc fuzijama
|
|
EP3311824B1
(en)
|
2013-02-05 |
2020-03-25 |
The Board of Trustees of the Leland Stanford Junior University |
Cd47 targeted therapies for the treatment of infectious disease
|
|
CN105189556A
(zh)
|
2013-03-15 |
2015-12-23 |
小利兰·斯坦福大学托管委员会 |
用于实现治疗有效剂量的抗cd47剂的方法
|
|
WO2014179132A1
(en)
|
2013-04-29 |
2014-11-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Use of anti-cd47 agents to enhance immunization
|
|
ES2765483T3
(es)
|
2013-09-18 |
2020-06-09 |
Univ Leland Stanford Junior |
Modulación de las vías de eferocitosis para el tratamiento de una enfermedad aterosclerótica
|
|
US11046763B2
(en)
|
2014-01-08 |
2021-06-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Targeted therapy for small cell lung cancer
|
|
WO2015138600A2
(en)
|
2014-03-11 |
2015-09-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Anti sirp-alpha antibodies and bi-specific macrophage enhancing antibodies
|
|
WO2016023040A1
(en)
|
2014-08-08 |
2016-02-11 |
Alexo Therapeutics International |
Sirp-alpha variant constructs and uses thereof
|
|
ES2751915T5
(es)
|
2014-08-15 |
2022-12-23 |
Merck Patent Gmbh |
Proteínas de fusión de inmunoglobulina con SIRP alfa
|
|
ES2945588T3
(es)
|
2014-08-26 |
2023-07-04 |
Univ Leland Stanford Junior |
Injerto de células madre con una combinación de un agente dirigido a las células madre y modulación de señalización inmunoreguladora
|
|
EP3012271A1
(en)
|
2014-10-24 |
2016-04-27 |
Effimune |
Method and compositions for inducing differentiation of myeloid derived suppressor cell to treat cancer and infectious diseases
|
|
WO2016065329A1
(en)
|
2014-10-24 |
2016-04-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for inducing phagocytosis of mhc class i positive cells and countering anti-cd47/sirpa resistance
|
|
EP3247464B1
(en)
|
2015-01-21 |
2019-09-18 |
The Board of Trustees of the Leland Stanford Junior University |
Use of tlr agonist and anti-cd47 agent to enhance phagocytosis of cancer cells
|
|
US10618976B2
(en)
|
2015-06-16 |
2020-04-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
SIRP-α agonist antibody
|
|
JP7032304B2
(ja)
|
2015-07-28 |
2022-03-08 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
キメラ抗原受容体を発現する改変された単球／マクロファージおよびその使用
|
|
ES2894335T5
(es)
|
2015-08-26 |
2024-06-27 |
Univ Leland Stanford Junior |
Reducción mejorada de células objetivo con bloqueo de CD47 y un agonista coestimulador inmune
|
|
DK4186927T3
(da)
|
2015-10-21 |
2025-06-10 |
Ose Immunotherapeutics |
Fremgangsmåder og sammensætninger til at ændre makrofagers polarisering til pro-inflammatoriske celler til behandling af kræft
|
|
US10946042B2
(en)
|
2015-12-01 |
2021-03-16 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for selective phagocytosis of human cancer cells
|
|
KR102988978B1
(ko)
|
2015-12-11 |
2026-07-10 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
Cd47 및 egfr의 이중 표적화를 이용한 암의 치료
|
|
EP3442541B1
(en)
|
2016-04-10 |
2021-11-17 |
Georgia State University Research Foundation, Inc. |
Composition for use in treating cancer
|
|
PH12018550160B1
(en)
|
2016-04-14 |
2024-07-03 |
Ose Immunotherapeutics |
NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
|
|
WO2018008470A1
(ja)
|
2016-07-05 |
2018-01-11 |
国立大学法人神戸大学 |
抗腫瘍剤
|
|
EP3493845A4
(en)
|
2016-08-03 |
2020-04-15 |
The Board of Trustees of the Leland Stanford Junior University |
INTERRUPTION OF FC RECEPTOR USE ON MACROPHAGES TO IMPROVE THE EFFECTIVENESS OF ANTI-SIRPALPHA ANTIBODY THERAPY
|
|
JOP20190009A1
(ar)
|
2016-09-21 |
2019-01-27 |
Alx Oncology Inc |
أجسام مضادة ضد بروتين ألفا منظم للإشارات وطرق استخدامها
|
|
CN110325549B
(zh)
|
2016-12-09 |
2024-03-08 |
艾利妥 |
抗SIRPα抗体及其使用方法
|
|
IL301075B2
(en)
|
2017-01-30 |
2024-05-01 |
Univ Leland Stanford Junior |
A genotoxic matching regimen for stem cell transplantation
|
|
PT3443010T
(pt)
*
|
2017-02-17 |
2024-10-21 |
Ose Immunotherapeutics |
Novos anticorpos anti-sirpa e suas aplicações terapêuticas
|
|
JP7160833B2
(ja)
|
2017-04-13 |
2022-10-25 |
サイロパ ビー．ブイ． |
抗ｓｉｒｐアルファ抗体
|
|
PT3625259T
(pt)
|
2017-05-16 |
2024-07-04 |
Synthon Biopharmaceuticals Bv |
Anticorpos anti-sirpalfa
|
|
EP3658589B1
(en)
|
2017-07-26 |
2023-09-27 |
Forty Seven, Inc. |
Anti-sirp-alpha antibodies and related methods
|
|
WO2019183266A1
(en)
|
2018-03-21 |
2019-09-26 |
ALX Oncology Inc. |
Antibodies against signal-regulatory protein alpha and methods of use
|
|
CR20200566A
(es)
|
2018-05-25 |
2021-02-19 |
Alector Llc |
Anticuerpos anti-sirpa y metodos de utilización de los mismos
|
|
MX2020013068A
(es)
|
2018-07-10 |
2021-03-02 |
Univ Kobe Nat Univ Corp |
Anticuerpo anti proteína reguladora de señales alfa sirpalfana.
|
|
SG11202102851XA
(en)
|
2018-09-27 |
2021-04-29 |
Celgene Corp |
SIRPa BINDING PROTEINS AND METHODS OF USE THEREOF
|
|
BR112021009325A2
(pt)
|
2018-11-14 |
2021-09-14 |
Arch Oncology, Inc. |
Anticorpo monoclonal, ou fragmento de ligação ao antígeno do mesmo; anticorpo biespecífico; método para prevenir ou tratar um câncer suscetível em um ser humano; método de ensaio de expressão de sirp¿ em células tumorais e/ou imunes; e; composição farmacêutica
|
|
CN113412279B
(zh)
|
2018-11-15 |
2024-09-24 |
拜奥迪斯私人有限公司 |
人源化抗SIRPα抗体
|